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Chronic renal failure is a progressive disease characterized by a gradual destruction of nephrons and a consequent reduction of
kidney function. End-stage renal disease (ESRD) necessitates renal replacement therapy as peritoneal dialysis, hemodialysis, or
transplantation. Patients affected by ESRD or in hemodialysis are at risk for developing a number of comorbidities including
hypertension, anemia, risk of bleeding, susceptibility to infection, medication side effects, and oral manifestations associated with
the disease itself and with hemodialysis treatment. In this context, oral diseases represent a potential and preventable cause of poor
health outcomes in people with ESRD due to their relation to infection, inflammation, and malnutrition. (e aim of this article
was to review ESRD and hemodialysis-associated manifestations and to describe the dental operative protocols for patients
awaiting kidney transplantation in light of the most recent literature.
1. Introduction
Oral health represents a potential determinant of health
outcomes in patients with end-stage renal diseases (ESRD).
Adults with ESRD have more severe oral diseases than the
general population, and dental conditions such as caries,
periodontitis, and poor oral hygiene are associated with
increased mortality. Oral pathologies are associated with
inflammation and malnutrition, which may accelerate
cardiovascular events in ESRD [1]. Furthermore, in the
context of kidney transplantation, infection from a dental
source is a potential threat for both organ transplant
candidates and recipients since dental disease is a ubiqui-
tous condition and is also likely to be more severe and
untreated in the transplant population [2].
(e present work reviews the literature on general and
specific considerations regarding the dental treatment of
ESRD patients in the pretransplant phase, considering the
systemic problems and treatment that may interfere with
clinical practice.
2. Chronic Renal Disease:
General Considerations
Chronic renal failure is a progressive disease characterized by
a gradual destruction of nephrons and a consequent reduction
of kidney function occurring over a few months or years [3].
As this process develops, the glomerular filtration rate (GFR)
falls while serum levels of urea rise. GFR is the rate at which
an ultrafiltrate of plasma is produced by glomeruli per unit
of time and is the best estimate of the number of functioning
nephrons or functional renal mass [4]. Normal GFR
values are approximately 120–130mL/min/1.73m2 and vary
according to age, gender, and body size [5]. All individuals
with a GFR <60mL/min/1.73m2 for 3months are classified as
having chronic kidney disease, irrespective of the presence or
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absence of kidney damage. (e reduction of GFR is usually
measured by creatinine clearance (CC), which gives an ac-
ceptable approximation of the value of GFR5. In clinical
practice, the CC can be indirectly assessed through serum
creatinine (normal values 0.5–1.4mg/dl) using several for-
mulas such as Chronic Kidney Diseases Epidemiologic
Collaboration (CKD-EPI) equation or the Modification of
Diet in Renal Disease (MDRD) equation.
(e progressive loss of renal function can be staged
through clinical, instrumental, and laboratory findings in the
following.
Stage 1: slightly diminished function—kidney damage
with normal or relatively high GFR (≥90mL/min/1.73m2).
Kidney damage is defined as pathological abnormalities or
markers of damage, including abnormalities in blood or urine
tests, biopsy, or imaging studies. Stage 2: mild reduction in
GFR (60–89mL/min/1.73m2) with kidney damage. Stage 3:
moderate reduction in GFR (30–59mL/min/1.73m2). Stage 4:
severe reduction in GFR (15–29mL/min/1.73m2)—prepa-
ration for renal replacement therapy. Stage 5: established
kidney failure or end-stage renal disease (ESRD) (GFR<15mL/min/1.73m2) requiring permanent renal replace-
ment therapy (RRT).
In 2004, KDIGO (Kidney Disease: Improving Global
Outcomes) added a specification regarding the concomitant
presence of a replacement therapy using the letter “T” for
transplanted patient and “D” for dialysis [6].
(e two main causes of ESRD are hypertension and
diabetes mellitus, both of which have a deleterious impact on
the cardiovascular system and renal apparatus of the patients
before and after transplantation. Particularly, cardiovascular
diseases (atherosclerosis) represent the main cause of death
in renal transplant recipients. Other causes of ESRD are
glomerulonephritis, chronic pyelonephritic urologic disor-
ders, and autoimmune diseases [7].(emost common cause
of death in ESRD patients is cardiac arrest, followed by
infection and malignancy [8].
Treatment of chronic renal insufficiency includes dietary
modifications and correction of systemic complications [8].
ESRD, also known as the uremic syndrome, necessitates
renal replacement therapy as dialysis or transplantation [4].
While stages 1 to 3 do not pose any contraindications for
routine dental treatment, patients with advanced kidney
disease (stages 4-5) require special considerations, most
importantly regarding hypertension, anemia, risk of bleeding,
infection and medication used, and oral manifestations as-
sociated with the disease itself and with hemodialysis treat-
ment [9].
3. ESRD and Dialysis
ESRD is characterized by diminished endocrine and met-
abolic functions of the kidney with subsequent retention and
accumulation of toxic metabolites. (e blood pressure is
increased due to fluid overload and production of vasoactive
hormones via the renin-angiotensin system, increasing the
risk of developing congestive heart failure. As chronic
kidney disease progresses, the ability to produce renal hy-
droxylated 1,25 vitamin D diminishes and 1,25 vitamin D
deficiency ensues [10]. Erythropoietin synthesis is also de-
creased, potentially leading to anemia. Furthermore, anemia
increases the hemorrhagic tendency in uremia due to
qualitative platelet dysfunction. Platelet dysfunction is due
to both decreased platelet aggregation and impaired platelet
adhesiveness and is one of the main determinants of uremic
bleeding. (is impairment is multifactorial and includes
defects intrinsic to the platelet as well as abnormal platelet-
endothelial interaction. Uremic toxins and anemia also play
a role. Correction of platelet dysfunction is desirable in
patients who are actively bleeding or who are about to
undergo a surgical procedure (e.g., renal biopsy). Platelet
dysfunction in the uremic patient can be controlled with the
administration of desmopressin, an analog of antidiuretic
hormone with little vasopressor activity, by the adminis-
tration of conjugated estrogens, or infusion of cry-
oprecipitate that can shorten the bleeding time in many
uremic patients [11–13].
(e ESRD patient also presents an immunodeficient
state caused by altered cellular immunity associated with
malnutrition, susceptibility to bacterial infection, and a di-
minished ability to produce antibodies [14].
A final consideration with respect to pharmacotherapy is
that most drugs are at least partially excreted via the kidney.
With renal dysfunction, the distribution, metabolism, bio-
availability, and rate of excretion of the drug are altered, and
an adjustment of the dosage by amount or by frequency is
required [5].
With advanced renal disease, aggressive measures such
as dialysis must be taken. Dialysis is a life-saving in-
tervention that has significantly prolonged life expectancy in
young patients. Hemodialysis is allowed by a machine
(dialyzer) that contains semipermeable membranes. (ese
membranes permit the passage of excessive fluid and wastes.
Arteriovenous shunts or fistulas achieve the access to the
bloodstream. (e continuous accumulation of toxic prod-
ucts in ESRD requires that the patient undergoing hemo-
dialysis receive the treatment for approximately three-four
hours a day, three times a week. It is important to point out
out that the efficiency of this process is much lower than
a functioning kidney, hence ESRD patients on hemodialysis
are in a constant state of kidney failure and hyperuremia.
(e constant presence of the uremic syndrome even in
hemodialyzed patients has been forwarded as a primary
contributor to the many systemic complications seen in
these patients.
Peritoneal dialysis (PD) offers greater independence;
access to the peritoneum is achieved by a catheter through
the abdominal wall into the peritoneum that serves as
a membrane able to filter the catabolic products from the
local vessels [9]. Although hemodialysis and PD correct
many of the hematologic dysfunctions associated with
uremia, several issues already present in ESRD are exacer-
bated during the treatment. Hemodialysis requires the use of
anticoagulant in the form of regional or systemic heparin to
maintain access patency and facilitate the filtration of toxic
blood compound such as urea through the dialysis mem-
brane [4]. Heparinization associated with mechanical
trauma to platelets can reduce the total platelet number and
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increase hemorrhagic risk. (is tendency is worsened by the
already present capillary fragility and anemia. Furthermore,
patients tend to have hypertension attributed to salt and
water retention and to activation of the rennin-angiotensin-
aldosterone [15, 16].
Sudden death is the most common cause of death in
dialyzed patients but also infection is a frequent cause of
morbidity and mortality in patients receiving hemodialysis
therapy. Due to the vascular access, patients are at increased
risk of endarteritis and endocarditis that occurs in about
2.7% of patients during hemodialysis and in 9% of those who
have an infection of the vascular access [17].
4. Oral Manifestations
It has been estimated that 90% of chronic renal failure
patients present oral symptoms. However, with the im-
provements of hemodialysis technology many of the oral
manifestations of renal failure and uremia described below
are less commonly seen [4].
Oral manifestations involve mucosal and glandular
tissues, the gingival and the periodontal apparatus, the
maxillary andmandibular bone, and finally the dental status.
Primarily, in regard with the mucosal and glandular
involvement, the most common oral finding in dialyzed
patient is pallor of the mucosa due mainly to anemia (re-
duced erythropoietin synthesis) [5, 15]. Bleeding tendency in
these patients is sustained by alterations in platelet aggre-
gation and renal anemia [15, 18]. Also, hemodialysis pre-
disposes to ecchymoses, petechiae, and hemorrhage in the
oral mucosa [5, 19, 20].
Xerostomia denotes the subjective sensation of dry mouth
and is related to the overall volume status of the patients who
are discouraged from drinking excess fluids and who are often
prone to retrograde parotitis [9, 15, 20, 21]. In association with
xerostomia, one third of hemodialyzed patients present
a characteristic halitosis called “uremic fetor” and a metallic
taste due to high urea content in saliva and its breakdown in
ammonia [5, 9]. Also, the patient can perceive altered sweet
and acid flavors due to high levels of urea in saliva and to the
presence of dimethyl and trimethyl amines. A burning sen-
sation of lips and tongue and an enlarged tongue sensation
may be additional symptoms noted by dialyzed patients [5].
An important problem is represented by uremic stomatitis,
which is a relatively uncommon oral complication of un-
known etiology [5, 18]. (e lesions consist of localized or
generalized erythematous areas covered by pseudomem-
branous exudates that can be removed, leaving an intact or
ulcerated mucosa. (e lesions are commonly painful and
most often appear on the ventral tongue and anterior mucosal
surfaces. (ey usually heal spontaneously with resolution of
the underlying uremia and after lowering of the blood urea
nitrogen (BUN) level [9]. However, in order to promote the
healing of the lesions, gargling with 10% hydrogen peroxide 4
times a day can be recommended [5, 19]. Angular cheilitis has
been reported in more than 4% of patients receiving he-
modialysis, and lichenoid disease may arise associated with
antihypertensive medication [5, 8]. Secondarily, pointing the
attention on the periodontal health, patients undergoing
hemodialysis generally have a poor objective periodontal
status verified by mean CPITN (Community Periodontal
Index of Treatment Needs), and deposit of calculus and
plaque may be increased [5, 8, 22, 23]. Studies have shown
that dental care in patients undergoing hemodialysis is
neglected, and that they brush and floss infrequently [15].
Results of a study by Naugle et al. suggested that 100% (n �
45) of the individuals undergoing renal dialysis presented
with some form of periodontal disease [24]. Moreover, di-
abetic nephropathic patients show deeper periodontal pockets
compared with ESRD nondiabetic patients [25]. Also, the
need for surgical treatment of periodontitis is significantly
higher in patients awaiting kidney transplant compared with
patients not undergoing organ transplantation [26]. Peri-
odontitis itself contributes to systemic inflammation and has
been associated with adverse hemodialysis outcomes in-
cluding mortality [27]. (e accelerated periodontal disease
with pocket formation, gingival recession, and bone and tooth
loss is due not only to inadequate oral hygiene and in-
flammatory disease burden but also to renal osteodystrophy
[5, 15].
Maxillary and mandibular bone tissue is interested by
renal osteodystrophy that results from disorders in calcium,
phosphorus, and vitamin D metabolism and from increased
parathyroid activity. Oral manifestations of renal osteo-
dystrophy include toothmobility, malocclusion, pulp stones,
enamel hypoplasia, bone demineralization, decreased tra-
beculation of cancellous bone, decreased thickness of cor-
tical bone, radiolucent giant cell lesions, jaw fracture
(spontaneous or after dental procedures), and abnormal
bone healing after extraction [5, 9, 20]. To avoid hypo-
vitaminosis D and its consequences, it is therefore necessary
to administer calcitriol or its analogs to compensate for the
compromised production of 1,25 vitamin D, which occurs in
the later stages of chronic kidney disease (beyond stage 3) so
that the classical functions of hormonal 1,25 vitamin D may
be addressed [10].
Finally, in regard with dental tissue involvement, a lower
rate of caries has been observed. (is finding can be
explained by the possible antibacterial effect of a higher urea
concentration in saliva that inhibits plaque and bacteria
development [9, 15]. (e antibacterial effect has been at-
tributed to the increase of pH due to urea hydrolization by
saliva, which suggests a protective function against caries
[5, 16]. Dental erosions due to frequent regurgitation
resulting from the nausea associated with hemodialysis
treatments and pulp narrowing and calcification are other
signs that the patient can present [4]. Enamel hypoplasia and
delayed eruption can occur in children with chronic renal
diseases [5, 28].
(e oral condition of patients with renal failure has been
described comprehensively in a recent meta-analysis by
Ruospo et al. [29]. Authors clearly separated the prevalence
of oral diseases in adults with ESRD, ESRD plus hemodi-
alysis, and transplantation and explored any association
between oral disease and mortality. (ey found that DMFT
indices were similarly high in adults with chronic kidney
disease (CKD) stages 1–5 (18.7 [C.I. 95% 10.5–27.0]) and
those with CKD stage 5D (14.5 [C.I. 95% 12.7–16.3]), and the
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mean DMFTindex increased with age but was not associated
with gender or dialysis duration. Periodontitis affected
31.6% of adults with CKD stages 1–5 and 58% of patients in
dialysis. (e prevalence of periodontitis in stage 5D was
unaffected by age, but increased with the proportion of
women and duration of dialysis. (e mean plaque index was
1.14 and 1.62 in two population with CKD stages 1–5 and
2.19 in kidney transplanted recipients. In stage 5D, the mean
plaque index was 1.9 and increased with age but was not
influenced by gender or time treated with dialysis. Regarding
mucosal diseases, ulcerations affected 8.6% of patients in
stage 5D and 1.3% of transplant recipients and candidiasis
affected 22.2% of patients in stage 1–5, 19% of adults with
CKD in stage 5D, and 13.3% of kidney-transplanted patients.
(e prevalence of oral candidiasis in stage 5 increased with
age but not gender, time of dialysis, or geographical region.
Xerostomia was reported by 48.4% of patients in stage 5D;
the mean stimulated predialysis salivary flow rate was
0.86ml/min for CKD stage 5D whereas the mean unsti-
mulated salivary flow rate was 0.22ml/min.
5. General Considerations for
Dental Management
Patients with renal disease in conservative medical treatment
or with PD do not generally require special measures re-
garding dental treatment, apart from avoiding nephrotoxic
drugs (such as tetracyclines or aminoglycosides) and
monitoring blood pressure during the procedures due to the
frequent hypertension [5].
However, for hemodialysis patients, communication
with the nephrologist is highly recommended in order to
know the stage of the pathology, the medications prescribed,
and comorbidities such as diabetes that negatively influence
the homeostasis of these patients [5].
In diabetic dialysis patients, hypoglycemic agents and
nutritional alterations can trigger hypoglycemia in the
background of diminished gluconeogenesis, reduced insulin
clearance by the kidney, and improved insulin sensitivity
following initiation of renal replacement therapy. Detailed
evaluation of antidiabetic regimen and nutritional patterns,
patient education on self-monitoring of blood glucose,
and/or referral to a diabetes specialist may reduce risk of
subsequent hypoglycemia [30].
Other important features to take into consideration are
drug intolerance and increased susceptibility to infection.
5.1. Risk of Bleeding. Dental treatment with risk of bleeding
should be postponed to nondialysis day since the antico-
agulant effect of heparin is absent, the bloodstream is free
from toxic metabolites, and the patient is not debilitated by
the treatment.
(e administration of a heparin antagonist (protamine
sulphate) can reduce the rate of bleeding in case of urgency.
However, a persistent bleeding tendency remains due to
anemia and alteration in platelet aggregation and adhe-
siveness. A hematologic study before planning any invasive
treatment can give information about coagulation times,
platelets count, hematocrit, and hemoglobin. In renal pa-
tients taking warfarin, International Normalized Ratio (INR)
should be measured. Evidence-based medicine states that
minor surgical procedure can be safely carried out without
adjustment for INR<4 although for INR>2.5, a consultation
with nephrologist is indicated [3, 31]. After the treatment,
local hemostatic measures (compression, cold applications,
tranexamic acid, cellulose sponges, and sutures) can be used
in case of local hemorrhage and are generally sufficient to
obtain hemostasis.
5.2. Medications. Local anesthetics can be safely used be-
cause they have a hepatic elimination. Paracetamol remains
the best choice for pain management, and also codeine can
be used without modification of the dosages. Other anti-
inflammatory drugs such as ketoprofen, ibuprofen, or
naproxen could cause hypertension and worsen the bleeding
tendency. Aspirin is contraindicated because it increases
platelet dysfunction, the risk of gastric hemorrhage, and
contributes to the deterioration of renal function. In case of
doubts, the nephrologist or the personal physician should be
consulted.
Patients who have been treated with high doses of
corticosteroids for a long time and or in stressful situations
may require steroid supplementation prior to dental treat-
ment to avoid an episode of adrenal crisis [5]. Moreover, it is
suggested that dental sessions should take place in the
morning, in a quiet environment and that abrupt and un-
expected movements be avoided during therapy [3].
5.3. Antibiotic Prophylaxis and ,erapy. Recent studies
pointed out the lack of scientific evidence to prescribe anti-
biotic prophylaxis for preventing infective endocarditis (IE) in
ESRD patients [15, 32]; ESRD or hemodialysis do not rep-
resent a criterion for IE prophylaxis. According to the
American Heart Association guidelines, antibiotic adminis-
tration remains indicated for patients suffering from con-
comitant cardiac comorbidities such as those with prosthetic
cardiac valve, previous IE, unrepaired cyanotic congenital
heart disease (CHD), completely repaired congenital heart
defect with prosthetic material or device during the first six
months after the procedure, repaired CHD with residual
defects at the site or adjacent to the site of a prosthetic patch or
prosthetic device, and cardiac transplantation recipients who
develop cardiac valvulopathy [33]. Nevertheless, patients
affected by ESRD have an increased susceptibility to IE es-
pecially if they do not have a good control of the disease [34].
Furthermore, patients in hemodialysis can develop infections
of the vascular access (endarteritis) that can become itself the
source of bacteraemia, and thus they may benefit from an-
tibiotic prophylaxis, especially in the 6 months after the
creation of the vascular access [35]. Due to these persisting
controversies, the best practice remains the discussion with
the patient’s nephrologist to evaluate, case by case, the in-
dication for an antibiotic prophylaxis.
In the presence of an acute or re-exacerbated dental
infection (periapical periodontitis, periapical, or periodontal
abscess), a complete cycle of antibiotic therapy should be
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administered using nonnephrotoxic antibiotics and taking
into consideration the CC because as renal function is re-
duced, the plasma levels of some drugs may be high or
prolonged [4]. (e CC test assesses glomerular function
comparing the amount of creatinine in the blood with that
eliminated in the urine over a day. (eoretically, a 50% drop
in CC represents a twofold increase in the half-life of a drug
eliminated solely via renal excretion [9]. For this reason,
according to the degree of renal elimination of the drug, the
interval between doses should be increased.
Penicillin and its derivatives, clindamycin and cepha-
losporins are safer antibiotics for these patients [5]. Ami-
noglycosides, tetracyclines, and polypeptide antibiotics
should be avoided because of their nephrotoxicity [4].
5.4. Psychological Aspect. Finally, it is extremely important to
remember the psychological aspect in treating ESRD or
hemodialyzed patients [4]. A poor quality of life and depression
have been associated with hemodialysis, and a reduction of
compliance should be expected in a higher percentage of
patients compared with general population [36, 37].
However, it is debatable whether systemic alterations
and general morbidity are casually associated with the worse
dental and periodontal status or if the hemodialysis per se
in combination with psychological factor may impact on
quality of life [38].
Recently, Pakpour et al. investigated the oral health-
related quality of life (OHRQoL) related to sociodemo-
graphic variables, clinical findings, cognitive variables, oral
health behaviours, and general health-related quality of life
(GHRQoL) in ESRD patients undergoing hemodialysis [39].
Patients were matched with a healthy control group. Results
showed that patients on hemodialysis had poor oral health
status, OHRQoL, and GHRQoL compared to healthy sub-
jects. Sociodemographic variables, oral health knowledge,
hygiene attitudes, and GHRQoL predicted OHRQoL.
Conversely, Schmalz et al. did not find neither clinical
nor statistical significant differences of Oral Health Impact
Profile (OHIP G14) between patients on hemodialysis and
control group although ESRD patients exhibited worse oral
health [38]. (is result highlights that the patient’s per-
ception does not reflect the oral deficiencies and that edu-
cation and motivation of these patients represent a focus in
oral health maintenance.
6. Operative Protocols
An increased perception of the importance of oral health in
ESRD patients and transplant candidates has been observed
in the scientific community in the last twenty years. Over
time, the dental protocols that have been proposed by
various authors showed a growing attention to the psycho-
logical aspect of the patient and to the importance of
maintaining good control of plaque and daily oral hygiene
[5, 6, 9, 16, 31, 40]. Due to the greatly increased incidence and
severity of periodontitis in the hemodialysis population, the
dentist should keep in mind that the lack of oral hygiene may
put the patient at higher risk of local or disseminated infection
because of the persisting daily episodes of bacteraemia from
the oral cavity. (e spread of oral bacteria can be minimized
by the elimination of oral foci and by reducing the grade of
mucosal and gingival inflammation. A good control of oral
hygiene and the absence of dental foci represent a funda-
mental step to receive a preemptive kidney transplant before
the patient needing dialysis, if medically suitable, thanks to
a living donor. Also, an efficient dental treatment with
maintenance of good oral hygiene is essential in the post-
transplant phase, especially by preventing the occurrence of
severe infections and consequently the survival of the
transplanted organ. Furthermore, adequate plaque removal
and the treatment of gingivitis and periodontitis can avoid or
minimize gingival hypertrophy due to assumption of im-
munosuppressive drugs such as cyclosporine [41].
Besides the knowledge of general health aspects dis-
cussed above, the dental practitioner has to know the correct
practical approach and the operative sequences to follow
when treating renal patients. From the first appointment, it
is fundamental to impress upon the patient the importance
of adequate oral health and explaining to them the possible
complications arising from untreated oral foci, both in the
pre- and posttransplantation phases, and the possible oral
side effects of taking future antirejection therapy [16, 42, 43].
As already mentioned, an accurate medical history should
be collected with particular reference to ESRD-related ill-
nesses, medications and their dosage, blood parameters,
timing, and type of dialysis performed. (ese aspects have to
be directly discussed with the nephrologists when necessary
[5, 44]. (e dental exam consists of a noninvasive complete
assessment of dental, periodontal, and mucosal tissues [9].
Special care should be taken when positioning the patient,
avoiding compression of the arm with the vascular access for
hemodialysis [5]. All possible foci (periodontal and end-
odontic lesions, residual roots, partially erupted and mal-
positioned third molars, and peri-implantitis) and oral
pathologies (caries and mucosal lesions) have to be inter-
cepted. Radiographs (orthopantomography and intraoral
x-rays) complete the diagnostic process both in dentate and
edentulous patients. Furthermore, a periodontal chart should
be performed if periodontitis is suspected.(e treatment plan
for periodontal disease must include the assessment of the
patient’s oral hygiene. (erapy of gingivitis and periodontitis
should consist primarily in accurate motivation and in-
struction for home oral hygiene, adapted and personalized to
the necessities of the patient. Mechanical removal of supra-
and subgingival calculus should be performed with ultra-
sound devices and curettes.
Carious lesions must be recognized and when necessary
pulp vitality should be tested. In the presence of pulp necrosis
and/or apical lesions, endodontic treatment, apicectomy, or
extraction can be programmed. Generally, extractions are
recommended when conservative, endodontic, and peri-
odontal treatments do not guarantee the complete resolution
of the pathology [3, 4, 20]. Extraction of partially erupted and
malpositioned third molars is recommended to avoid peri-
coronal infection especially in the early posttransplant period.
In cases of peri-implantitis, surgical removal of the implant
should be performed. (e surgery should be as atraumatic as
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possible to avoid maxillo-mandibular fractures due to renal
osteodystrophy. In the presence of suspected mucosal lesions
that do not resolve in 7–10 days, a biopsy must be performed.
Before any procedure that could lead to bleeding (periodontal
chart, calculus removal with ultrasound, subgingival scaling,
extraction, and periodontal surgery) a 15ml rinse of chlo-
rhexidine 0.12% for 60 seconds is recommended to reduce the
amount of oral bacteria that could reach the bloodstream.
Adaptation of removable prostheses should be assessed to
determine the necessity of adjustment or substitution, and the
patient should be instructed regarding the cleaning and
maintenance of the device [3].
Orthodontic appliances can be maintained if they do not
interfere with oral hygiene. (e removal of orthodontic
FIRST ASSESSMENT 
1.Explain extensively the aims of the dental treatment and discuss with the patient the importance of adequate oral health;
obtain a written informed consent.
2. Collect a complete medical history and, if necessary, contact the nephrologist to assess the grade of ESRD, ESRD-related 
illnesses, timing, and type of dialysis.
3. Perform a noninvasive examination of dental, periodontal, and mucosal tissues. Complete the examination with
radiographs both in dentate and edentulous patients.
4. Recognize all possible foci (periodontal and endodontic lesions, residual roots, partially erupted and malposed third molars, 
and peri-implantitis) and oral pathologies (caries and mucosal lesions).
Dental Foci
YES
Dental Foci
NO
DENTAL TREATMENT (General considerations)
1. Before any procedure that could lead to bleeding, a 15ml rinse of chlorhexidine 0.12% for 60 seconds is 
recommended.
2. Antibiotic prophylaxis should be considered before surgery.
3. Dosage of pharmacologic therapies must be adapted to the creatinine clearance. In general, avoid 
administration of aspirin and consider safe local anesthetic.
4. Organize the patient appointments on the day after hemodialysis.
Prosthetic and
orthodontic devices
1. Assess the adaptation
of removable prostheses
to determine the necessity
of adjustment or
substitution.
2. Check orthodontic
appliances and maintain
them if they do not
interfere with oral
hygiene (the removal of
orthodontic brackets is
suggested just before
transplantation).
3. Instruct the patient
regarding the correct
cleaning and maintenance
of the devices.
Oral surgery
1. Use an atraumatic
technique to avoid the risk
of bone fractures.
2. Extract residual roots,
teeth with high mobility,
and elements with
periodontal or endodontic
lesion that are not
maintainable.
3. Extract partially erupted
and malpositioned third
molars to avoid pericoronal
infection especially in the
early posttransplant period.
4. Treat peri-implantitis or
perform the surgical
removal of unmaintainable
implants.
5. Proceed with the biopsy
of suspected mucosal
lesions.
Periodontal therapy
1. Take into account the
assessment of the
patient’s oral hygiene.
2. In cases of 
periodontitis, perform a
complete periodontal
chart.
3. Proceed with the
mechanical removal of
supra-and subgingival
calculus with ultrasounds
devices and curettes.
4. Program surgical
periodontal therapy when
indicated and only if a
good prognosis is
expected. Otherwise,
proceed with extraction.
5. Motivate and instruct
home oral hygiene.
Conservative-
endodontic therapy
1. Recognize carious
lesions and proceed with
decayed tooth restoration.
2. Test pulp vitality on
teeth with extensive
caries. In presence of
pulp necrosis and/or
apical lesions (diagnosed
by radiographs), proceed
with the endodontic
treatment.
3. Extraction is
recommended when the
endodontic treatment
does not guarantee the
complete resolution of the
pathology.
RECALL PROGRAM
1. Insert all patients in a strict recall program (frequency range of 3–6 months)
2. Repeat a complete noninvasive examination of the oral cavity and radiographs if the presence of new foci is suspected.
check prostheses and orthodontic appliances.
3. Treat the patients for new pathologies.
Figure 1: Flowchart for dental treatment of ESRD and hemodialyzed patients.
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brackets is indicated just before transplantation because the
immunosuppressive therapy administered in the posttrans-
plant period can induce gingival overgrowth that seems to be
muchmore accentuated in the presence of fixed appliances [3].
After the first cycle of dental therapy, it is crucial that all
patients are included in a strict follow-up program to
maintain the results obtained and, above all, to maintain
a high level of compliance. (e frequency of follow-up
depends on the needs and motivation of the patient (3–
6months for effective plaque control) [45]. Since the patients
undergo hemodialysis with a frequency of about three times
a week for approximately 2–4 hours per session (plus their
other medical appointments), they could be psychologically
affected and poorly compliant with respect to dental ap-
pointments. For this reason, the education on the impor-
tance of oral health is crucial to maintain the best motivation
of the patient. At each appointment, a review of medical
history is indicated and a complete noninvasive examination
of the oral cavity should be repeated [15]. Radiographs must
be performed if the presence of new foci is suspected.
It is important that this protocol is followed until the
patient undergoes renal transplantation. In fact, the ad-
herence to periodic follow-up reduces the risk of oral in-
fection just before the transplant and avoids the possibility of
losing the compatible organ because of an acute infection
from a dental source [15].
Operative protocols from first access to follow-up visit
are summarized in Figure 1.
7. Conclusion
CKD has become a major public health problem worldwide,
and terminal stage of CKD, ESRD, requires renal re-
placement therapy or kidney transplant [46, 47].
(e number of patients needing a kidney transplant is
increasing, and as this group of patients grows, its dental
needs will also increase.
It is important to coordinate with the nephrologist the
dental intervention considering the possible deterioration of
general conditions of the patient during and after the dental
treatment.
Patients have to be treated considering all issues cor-
related to the kidney dysfunction and inserted in a strict
follow-up program until transplantation. Early detection of
oral pathologies and strong preventive measures can min-
imize the need for extensive dental care [48]. (e in-
volvement of the patient is central to increase the motivation
for oral health.
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